• OPEN AN ACCOUNT
Indian Indices
Sensex
74,656.48 -202.51
( -0.27%)
Global Indices
Nasdaq
52,073.35 369.71
(0.72%)
Dow Jones
7,785.28 113.78
(1.48%)
Hang Seng
65,040.24 903.99
(1.41%)
Nikkei 225
10,737.46 78.33
(0.73%)
Forex
USD-INR
95.99 0.12
(0.12%)
EUR-INR
110.24 0.24
(0.22%)
GBP-INR
128.54 0.36
(0.28%)
JPY-INR
0.61 0.00
(-0.53%)

EQUITY - MARKET SCREENER

Gennex Laboratories Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
531739
INE509C01026
8.9778497
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
15.12
249.75
EPS(TTM)
Face Value()
Div & Yield %
0.68
1
0
 

balaxi pharmaceuticals ltd
Rapicut Carbides standalone net profit rises 96.97% in the March 2026 quarter
Jun 01,2026
Net profit of Rapicut Carbides rose 96.97% to Rs 0.65 crore in the quarter ended March 2026 as against Rs 0.33 crore during the previous quarter ended March 2025. Sales rose 370.52% to Rs 49.31 crore in the quarter ended March 2026 as against Rs 10.48 crore during the previous quarter ended March 2025.

For the full year,net profit reported to Rs 2.06 crore in the year ended March 2026 as against net loss of Rs 2.33 crore during the previous year ended March 2025. Sales rose 129.29% to Rs 96.28 crore in the year ended March 2026 as against Rs 41.99 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales49.3110.48 371 96.2841.99 129
OPM %0.937.16 -3.11-2.50 -
PBDT0.540.50 8 2.67-1.75 LP
PBT0.400.37 8 2.11-2.25 LP
NP0.650.33 97 2.06-2.33 LP